Offer An Article

Pandemic Latest News

AstraZeneca

RSV

FDA approves RSV maternal vaccine; The latest health stories from around the world

The U.S. Food and Drug Administration (FDA) has approved a vaccine given to pregnant women to protect babies from respiratory syncytial virus (RSV). The virus causes severe lung infections that are the leading cause of U.S. infant hospitalizations. https://www.science.org/content/article/rsv-vaccine-scientific-advisory-panels-and-biodiversity-hot-spot-risk?   Pregnant people who receive the vaccine, called Abrysvo and made by Pfizer, can pass protective antibodies […]

FDA approves RSV maternal vaccine; The latest health stories from around the world Read More »

Covishield: A single dose may be enough for those previously infected with COVID-19

New research claims that a single dose of Covishield may be sufficient to protect those previously infected with the novel coronavirus which causes COVID-19.  If someone has previously contracted severe acute respiratory syndrome coronavirus 2 (SARS-CoV), researchers at the Assam Medical College and the Indian Council of Medical Research (ICMR) suggest that they may not

Covishield: A single dose may be enough for those previously infected with COVID-19 Read More »

AstraZeneca medicine approved for kidney disease treatment

Chronic kidney disease (CKD) is an often neglected condition. Hope may be on the horizon as a medication has been approved in India produced by AstraZeneca.  The medication, dapagliflozin, is an AstraZeneca-produced medication that has previously been approved for use in the treatment of diabetes. The drug has, however, shown to have a high degree

AstraZeneca medicine approved for kidney disease treatment Read More »